REGULATED PRESS RELEASE published on 01/11/2024 at 15:09, 10 months 9 days ago Thales - number of shares and voting rights - December 2023 (French only) Société anonyme au capital de 630 630 420 € Siège social : 4 rue de la Verrerie 92190 Meudon. Informations relatives au nombre total de droits de vote et d’actions prévues par les articles L.233-8 II du Code de commerce et 223-16 du Règlement général de l’Autorité des marchés financiers. Date : 31-12-2023. Nombre d’actions : 210 210 140. Nombre de droits de vote théoriques : 307 132 148. Nombre de droits de vote exerçables : 303 590 362. Meudon, 11 janvier 2024. Autorité Des Marchés Financiers Société Anonyme Capital Droits De Vote Code De Commerce
REGULATED PRESS RELEASE published on 11/10/2023 at 15:52, 1 year ago Thales - Number of shares and voting rights - October 2023 (French only)
REGULATED PRESS RELEASE published on 10/31/2023 at 07:00, 1 year ago Thales reports its order intake and sales for the third quarter of 2023 - Press release - 31 October 2023
REGULATED PRESS RELEASE published on 10/11/2023 at 21:00, 1 year 1 month ago Thales finalizes the financing of its contemplated Imperva acquisition, issuing a €1.8bn bond - Press release - 11 October 2023
REGULATED PRESS RELEASE published on 10/09/2023 at 11:05, 1 year 1 month ago Thales - Number of shares and voting rights - September 2023 (French only)
REGULATED PRESS RELEASE published on 10/04/2023 at 08:40, 1 year 1 month ago Thales - Press release - Thales closes deal on Tesserent, strengthening its global cybersecurity business - 4 October 2023
REGULATED PRESS RELEASE published on 10/02/2023 at 08:45, 1 year 1 month ago Thales - Press release - Thales announces a new appointment to the Board of Directors - October 2, 2023
Published on 11/21/2024 at 13:30, 16 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 16 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 46 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 46 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 46 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 11 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 31 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 48 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 26 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 1 minute ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 1 minute ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo